4//SEC Filing
Norchi Terrence W 4
Accession 0001415889-22-007596
CIK 0001537561other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:55 PM ET
Size
11.0 KB
Accession
0001415889-22-007596
Insider Transaction Report
Form 4
Norchi Terrence W
DirectorPres, CEO, Sec, and Treas10% Owner
Transactions
- Award
Common Stock
2022-07-06+72,435→ 2,981,512 total - Award
Senior Secured Convertible Notes
2022-07-06→ Common Stock (525,164 underlying) - Award
Warrants
2022-07-06+482,897→ 482,897 totalExercise: $0.05From: 2022-07-06Exp: 2027-07-06→ Common Stock (482,897 underlying)
Holdings
- 10,000,000(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]The shares of common stock, senior secured convertible notes (the "Notes") and warrants were issued to the Reporting Person in connection with a convertible note offering entered into by the Reporting Person and the Issuer (the "Offering"), which Offering was approved by the Issuer's Board of Directors and, in accordance with Rule 16b-3(d)(1) of the Exchange Act (the "Act"), is exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated thereunder.
- [F2]The Reporting Person disclaims beneficial ownership of the securities held by Twelve Pins Partners, LLC except to the extent of his pecuniary interest therein.
- [F3]The Notes become due and payable on January 6, 2024, bear interest at a rate of 10% per annum, are convertible at the option of the holder pursuant to certain provisions with an initial conversion price of $0.0457, contain customary events of default and are subject to certain beneficial ownership limitations.
- [F4]Conversion of the warrants is subject to certain beneficial ownership limitations.
Documents
Issuer
Arch Therapeutics, Inc.
CIK 0001537561
Entity typeother
Related Parties
1- filerCIK 0001579935
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 4:55 PM ET
- Size
- 11.0 KB